Target intelligence / Profile preview

SUCLA2 pseudogene 1 (SUCLA2P1)

Target
SUCLA2P1
Molecular classification
Other (Pseudogene)
01

Overview

SUCLA2 pseudogene 1 (SUCLA2P1) is a human pseudogene located on chromosome 6, related by sequence homology to the protein-coding gene SUCLA2, which encodes the beta subunit of succinyl-CoA ligase, an enzyme of the mitochondrial citric acid (Krebs) cycle. Pseudogenes such as SUCLA2P1 do not produce functional proteins and do not have known direct roles in normal biological pathways or human disease. There is no evidence to suggest that SUCLA2P1 serves as a therapeutic target, biomarker, or has interactions with drugs. The functionally important gene in this family is SUCLA2, not SUCLA2P1[7]. SUCLA2P1 is a pseudogene and does not produce a functional protein nor serve as a drug target or receptor. The canonical functional gene is SUCLA2 (Succinate-CoA ligase ADP-forming subunit beta, mitochondrial), which is distinct from SUCLA2P1[1][2][3][7]. No known drug interactions, disease roles, or therapeutic applications are associated with SUCLA2P1. If you are seeking structured data about the functional enzyme and its disease associations, refer instead to SUCLA2, not its pseudogene SUCLA2P1.

Other names
Em:AB014080.4SUCLA2P1SUCLA2 pseudogene 1

Beyond the preview

Go deeper on SUCLA2 pseudogene 1 (SUCLA2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SUCLA2 pseudogene 1 (SUCLA2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call